Published in Br J Cancer on January 01, 1997
Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis (2004) 1.37
Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study. Br J Cancer (1999) 1.31
How can research on plants contribute to promoting human health? Plant Cell (2011) 1.12
Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst (2014) 1.11
Zinc and zinc transporters in prostate carcinogenesis. Nat Rev Urol (2013) 1.11
A screen for suppressors of gross chromosomal rearrangements identifies a conserved role for PLP in preventing DNA lesions. PLoS Genet (2007) 1.06
Allium vegetables and organosulfur compounds: do they help prevent cancer? Environ Health Perspect (2001) 1.06
Dietary fat, fatty acids, and risk of prostate cancer in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev (2013) 1.04
Legume and isoflavone intake and prostate cancer risk: The Multiethnic Cohort Study. Int J Cancer (2008) 1.02
Zinc intake from supplements and diet and prostate cancer. Nutr Cancer (2009) 0.97
Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells. J Nutr (2008) 0.96
A case--control study of selenium in nails and prostate cancer risk in British men. Br J Cancer (2004) 0.94
Dietary zinc and prostate cancer survival in a Swedish cohort. Am J Clin Nutr (2011) 0.94
Diet, vegetarian food and prostate carcinoma among men in Taiwan. Br J Cancer (2005) 0.92
One-carbon metabolism-related nutrients and prostate cancer survival. Am J Clin Nutr (2009) 0.91
Dietary carrot consumption and the risk of prostate cancer. Eur J Nutr (2014) 0.90
Chemoprevention of bladder cancer. World J Urol (2006) 0.90
Cancer prevention and diet: help from single nucleotide polymorphisms. Proc Natl Acad Sci U S A (1999) 0.89
Lifetime total and beverage specific--alcohol intake and prostate cancer risk: a case-control study. Nutr J (2004) 0.84
Pathobiology and chemoprevention of bladder cancer. J Oncol (2011) 0.84
Lycopene and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.83
Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression. Am J Clin Nutr (2016) 0.82
Association between Dietary Vitamin C Intake and Risk of Prostate Cancer: A Meta-analysis Involving 103,658 Subjects. J Cancer (2015) 0.81
Associations between Intake of Folate, Methionine, and Vitamins B-12, B-6 and Prostate Cancer Risk in American Veterans. J Cancer Epidemiol (2012) 0.81
Iodine uptake and prostate cancer in the TRAMP mouse model. Mol Med (2013) 0.80
Utilization of prostate cancer screening according to dietary patterns and other demographic variables. The adventist health study-2. J Cancer (2013) 0.79
High-dose dietary zinc promotes prostate intraepithelial neoplasia in a murine tumor induction model. Asian J Androl (2009) 0.77
Folate intake, serum folate levels, and prostate cancer risk: a meta-analysis of prospective studies. BMC Public Health (2014) 0.77
Tomatoes, lycopene and prostate cancer: a clinician's guide for counseling those at risk for prostate cancer. World J Urol (2003) 0.76
Metabolite Analysis and Histology on the Exact Same Tissue: Comprehensive Metabolomic Profiling and Metabolic Classification of Prostate Cancer. Sci Rep (2016) 0.76
No association between fiber intake and prostate cancer risk: a meta-analysis of epidemiological studies. World J Surg Oncol (2015) 0.76
Novel spectrophotometric method for the quantitation of urinary xanthurenic acid and its application in identifying individuals with hyperhomocysteinemia associated with Vitamin B₆ deficiency. Biomed Res Int (2013) 0.75
Tomato consumption and prostate cancer risk: a systematic review and meta-analysis. Sci Rep (2016) 0.75
Validity of a web-based dietary questionnaire designed especially to measure the intake of phyto-oestrogens. J Nutr Sci (2016) 0.75
Zinc Intake and Risk of Prostate Cancer: Case-Control Study and Meta-Analysis. PLoS One (2016) 0.75
Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis (2017) 0.75
A Pooled Analysis of 15 Prospective Cohort Studies on the Association Between Fruit, Vegetable, and Mature Bean Consumption and Risk of Prostate Cancer. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer (1975) 7.20
The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol (1988) 5.32
Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst (1996) 4.66
Can dietary beta-carotene materially reduce human cancer rates? Nature (1981) 4.43
Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr (1994) 4.32
Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst (1995) 3.67
Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst (1995) 3.24
Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Oncol (1992) 3.08
Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer (1989) 1.91
Dietary beta-carotene, vitamin C, and risk of prostate cancer: results from the Western Electric Study. Epidemiology (1996) 1.48
A case-control study of cancer of the prostate in Somerset and east Devon. Br J Cancer (1996) 1.30
Nutrition and prostate cancer. Cancer Causes Control (1996) 1.20
Black tea consumption and cancer risk: a prospective study. Br J Cancer (1986) 1.15
Total food consumption and body mass index in relation to prostate cancer risk: a case-control study in Sweden with prospectively collected exposure data. J Urol (1996) 1.10
Garlic and its significance for the prevention of cancer in humans: a critical view. Br J Cancer (1993) 1.07
Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem Biophys Res Commun (1995) 1.05
Tea consumption and cancer. Br J Cancer (1988) 1.03
Risk factors for prostate cancer. Cancer Surv (1995) 1.01
A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancers. Int J Cancer (1994) 1.01
Alcohol use and prostate cancer risk in US blacks and whites. Am J Epidemiol (1996) 0.98
Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: a reevaluation of the effect of dietary beta-carotene. Am J Epidemiol (1991) 0.90
Novel functions of vitamin B6. Proc Nutr Soc (1994) 0.82
Dietary assessment methods. Br J Nutr (1995) 0.79
Protease inhibitors: possible anticarcinogens in edible seeds. Prostate (1983) 0.79
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1993) 11.01
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet (1994) 9.60
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet (1995) 9.06
Construction of linkage maps with DNA markers for human chromosomes. Nature (1985) 6.38
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science (1987) 5.11
Clinicians and the coronial system: ability of clinicians to recognise reportable deaths. BMJ (1993) 4.40
Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med (1988) 3.01
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr (1999) 2.78
A model for restriction fragment length distributions. Am J Hum Genet (1983) 2.71
Dietary habits and mortality in 11,000 vegetarians and health conscious people: results of a 17 year follow up. BMJ (1996) 2.61
The information content of phase-known matings for ordering genetic loci. Genet Epidemiol (1985) 2.59
Case-control study of whether subfertility in men is familial. BMJ (1994) 2.49
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet (2000) 2.26
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control (2001) 2.07
Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. Arch Dermatol (1996) 2.00
The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet (1986) 1.90
Dietary determinants of ischaemic heart disease in health conscious individuals. Heart (1997) 1.87
A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet (2001) 1.70
Attitudes of senior pathologists towards the autopsy. J Pathol (1994) 1.69
Measuring repeatability and validity of histological diagnosis--a brief review with some practical examples. J Clin Pathol (1983) 1.67
General practitioners, skin lesions and the new contract. J Public Health Med (1992) 1.66
Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma. Br J Dermatol (1992) 1.65
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol (1982) 1.61
Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med (1985) 1.58
Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis (2003) 1.54
Intron splice acceptor site sequence variation in the hereditary non-polyposis colorectal cancer gene hMSH2. Eur J Cancer (1994) 1.54
Diabetic nephropathy: a risk factor for diabetes mellitus in offspring. Diabetologia (1995) 1.54
Colonic polyps in an unselected population: prevalence, characteristics, and associations. Am J Gastroenterol (1994) 1.53
Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer (1999) 1.53
Frequency of replication errors in colorectal cancer and their association with family history. Gut (1998) 1.46
Five cases of coexistent primary ocular and cutaneous melanoma. Arch Dermatol (1993) 1.45
Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ (1990) 1.44
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol (2013) 1.43
Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas. Mol Pathol (2003) 1.42
Are relatives of patients with multiple HNPCC spectrum tumours at increased risk of cancer? Gut (1998) 1.42
What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries. Br J Cancer (2011) 1.41
Diet and body mass index in 38000 EPIC-Oxford meat-eaters, fish-eaters, vegetarians and vegans. Int J Obes Relat Metab Disord (2003) 1.39
Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2008) 1.38
Frequency of familial colorectal cancer. Br J Surg (1991) 1.38
Natural history of prostate cancer. Lancet (1993) 1.37
A segregation analysis of testicular cancer based on Norwegian and Swedish families. Br J Cancer (1997) 1.31
AT-tributable risks? Nat Genet (1997) 1.28
Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1. Hum Mol Genet (1993) 1.27
Nutrition, lifestyle and colorectal cancer incidence: a prospective investigation of 10998 vegetarians and non-vegetarians in the United Kingdom. Br J Cancer (2004) 1.27
Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies. Br J Cancer (1999) 1.26
The relationship between the epidermal growth factor (EGF) 5'UTR variant A61G and melanoma/nevus susceptibility. J Invest Dermatol (2004) 1.25
The impact of RFLPs on human gene mapping. Prog Clin Biol Res (1984) 1.24
A case-control study of dietary carotene in men with lung cancer and in men with other epithelial cancers. Nutr Cancer (1991) 1.21
A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer. J Med Genet (1999) 1.21
Cancer incidence in British vegetarians. Br J Cancer (2009) 1.19
Germline mutations of the CDKN2 gene in UK melanoma families. Hum Mol Genet (1997) 1.19
Effect of improved data collection on breast cancer incidence and survival: reconciliation of a registry with a clinical database. BMJ (2000) 1.17
Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data. Br J Cancer (1987) 1.15
Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76,000 men and women in five prospective studies. Public Health Nutr (1998) 1.14
A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer (1996) 1.14
Possible linkage of a breast cancer-susceptibility locus to the ABO locus: sensitivity of LOD scores to a single new recombinant observation. Genet Epidemiol (1984) 1.13
Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J Natl Cancer Inst (1993) 1.13
Distribution of lod scores under uncertain mode of inheritance. Am J Hum Genet (1993) 1.12
Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6q. Am J Hum Genet (1996) 1.09
Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. Gut (1993) 1.07
Germline BRCA2 mutations in men with breast cancer. Br J Cancer (1997) 1.07
Sex hormones in women in rural China and in Britain. Br J Cancer (1990) 1.06
Quantitating genetic and nongenetic factors that determine plasma sex steroid variation in normal male twins. Metabolism (1986) 1.06
The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study. Am J Hum Genet (1999) 1.06
Autozygosity mapping, complex consanguinity, and autosomal recessive disorders. J Med Genet (1993) 1.05
Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am J Epidemiol (2009) 1.05
Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer (1994) 1.04
The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br J Cancer (2005) 1.04
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst (2010) 1.04
Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosomes Cancer (1997) 1.03
Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ (1995) 1.03
Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. J Invest Dermatol (2000) 1.03
Nm23 'anti-metastatic' gene product expression in colorectal carcinoma. J Pathol (1994) 1.02
Linkage analysis of early-onset breast and ovarian cancer families, with markers on the long arm of chromosome 17. Am J Hum Genet (1993) 1.02
Comparison of allelic ratios from paired blood and paraffin-embedded normal tissue for use in a polymerase chain reaction to assess loss of heterozygosity. Mol Diagn (1999) 1.02
Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2009) 1.02
Mutation testing in melanoma families: INK4A, CDK4 and INK4D. Br J Cancer (1999) 1.01
A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum Mol Genet (2001) 1.01
A generalized war of attrition. J Theor Biol (1978) 1.01
Genetic susceptibility to colorectal cancer in patients under 45 years of age. Br J Surg (1994) 1.01
Mutation screening of the CDKN2A promoter in melanoma families. Genes Chromosomes Cancer (2000) 1.01
Catecholamines and experimental stress ulcer: morphological and biochemical changes in the gastric mucosa. Br J Surg (1980) 1.00
Heritability of variation of plasma cortisol levels. Metabolism (1988) 1.00
Melanoma sentinel node biopsy and prediction models for relapse and overall survival. Br J Cancer (2010) 0.99
Characteristics of familial colon cancer in a large population data base. Cancer (1989) 0.98
Suggested screening guidelines for familial colorectal cancer. J Med Screen (1995) 0.98
Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient. J Pathol (2001) 0.98
A retrospective observational study of the relationship between family history and survival from colorectal cancer. Br J Cancer (2013) 0.97
Muir-Torre syndrome: a variant of the cancer family syndrome. J Med Genet (1994) 0.97
Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage A1 (T1a) prostatic adenocarcinoma. Br J Urol (1994) 0.97
Identification of a modifier gene locus on chromosome 1p35-36 in familial adenomatous polyposis. Hum Genet (1997) 0.96
Quantitating genetic and nongenetic factors influencing androgen production and clearance rates in men. J Clin Endocrinol Metab (1988) 0.96
Health benefits of a vegetarian diet. Proc Nutr Soc (1999) 0.96